Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)

Nang Kuang Pharmaceutical Revenue

Nang Kuang Pharmaceutical had revenue of 529.63M TWD in the quarter ending March 31, 2026, a decrease of -8.60%. This brings the company's revenue in the last twelve months to 2.11B, down -6.15% year-over-year. In the year 2025, Nang Kuang Pharmaceutical had annual revenue of 2.16B, down -1.71%.

• Revenue (ttm): 2.11B
• Revenue Growth: -6.15%
• P/S Ratio: 1.57
• Revenue / Employee: 3.83M
• Employees: 552
• Market Cap: 3.32B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.16B	-37.64M	-1.71%
Dec 31, 2024	2.20B	49.63M	2.31%
Dec 31, 2023	2.15B	209.74M	10.81%
Dec 31, 2022	1.94B	160.39M	9.01%
Dec 31, 2021	1.78B	25.27M	1.44%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 28, 2026

Data Sources Report a data error